FIRST TR EXCHANGE TRADED FD (AMEX:FBT)

whomonkyoulus (28.88) Submitted: 9/21/2010 2:37:43 PM : Start Price: $32.11 FBT Score: +13.68

Along with the insider etf, NFO, this is my favorite, no, the absolute best of what an etf can do! People that put this one down simply do not understand it at all. I am calling you out. I am looking for one person so claim that he or she understands this etf and thinks that it will under-perform. This is unlike any other biotech etf....
How does a smart investor buy biotech.....?
He waits until a drop and buys in, knowing that it could drop more, but trying to diversify, because the upside is unbounded while the downside is. Then when a biotech pops, he sells take profits, catching the appreciation due to expectations, and selling before the final trial proves unsuccessful or the FDA asks the company to spend a year or two more clarifying something for them.
This etf mimics a smart biotech investor because it does not invest in the large biotechs that already have hit the jackpot and will slowly fall over the years because most investors do not know what we know, that the drug development process is mostly luck, just like picking biotechs. Therefore, there is no reason to invest 10x more in a 5billusd biotech than a 500mill cap stock; quite the opposite! This etf invests 5% in each of 20 companies, and then rebalances each quarter, taking profits from successes and putting more money into losers.

iddqkfyou (< 20) Submitted: 4/16/2010 2:12:38 PM : Start Price: $37.06 FBT Score: +7.94

This is my favorite Biotech ETF because it rebalances its portfolio every quarter to give equal weight to all biotechs, small startups and large established biotechs. That means they are heavily weighted towards the many small names with upside potential and automatically sell their stock after a big appreciation, not waiting for the company to fail down the line or destroy value with attempts to continue the pipeline.

Biotech has been on a log-linear path for years now... because it is not cyclical, it is developmental, a newly developing system. This is a new fronter. We all know about Moore's Law; it will not take long before someone quantifies our gene and protean knowledge discovery system in this way.

People will live longer and keep getting sick; they will start preserving stem-cells and umbilical cords. What will the wealthy children and governments spend their money on in the future if not this?

It is diversified, with the most convincing fundamentals I can think of, knowledge based (economy of scale), totally unconsolidated, and not very heavily dependent on the structurally and politically doomed USD.

ericcote1est (49.78) Submitted: 9/15/2009 9:01:48 AM : Start Price: $28.77 FBT Score: +26.48

ccest compte

reddingrunner (81.93) Submitted: 8/8/2007 3:19:02 PM : Start Price: $24.10 FBT Score: +88.84

Like they said.

Biotechs are risky individually- will the trials pan out or no?

But science will march on - somewhere, someone will come up with stuff that really does work. You could look it up.

Biotechs look cheap right now compared to their history and potential. If a couple of these companies hit it big, investors will rush to the sector (baaa!) and you'll probably see almost all of these stocks soar.

mikerigg86 (57.92) Submitted: 5/21/2007 11:15:20 AM : Start Price: $24.99 FBT Score: +84.04

Great fund of diversified biotech companies, which are often risky as single investments.

VALPODT (< 20) Submitted: 3/29/2007 5:06:19 PM : Start Price: $23.52 FBT Score: +88.15

As "boomers" age, the medical needs of that group will outpace drug development of the old pharma industry. Individual biotechs are too volatile. A basket is the most viable option.

FarnamStFool41 (48.99) Submitted: 3/17/2007 12:17:25 AM : Start Price: $22.40 FBT Score: +96.00

I lack the ability to sucessfully pick individual Biotech names, so I've got to go with the basket approach. Biotechs are too, too risky for my blood. Never know when your going to wake up to a 30% drop in your share price.